Close Menu

It seems no one is happy with the US debt deal — especially the research community. Both scientists and lobbyists say that prospective cuts in government spending may compromise disease research and hamper the careers of young researchers, say Bloomberg's Elizabeth Lopatto and Brian Faler. If Congress doesn't approve $1.5 trillion in cuts by Christmas, automatic cuts will go into effect that will affect NIH, NSF, and the US Department of Energy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.